Flanking Markers of Cystatin C (CST3) Gene Do Not Show Association with Alzheimer's DiseaseHELISALMI, Seppo; VÄKEVÄ, Antti; HILTUNEN, Mikko et al.Dementia and geriatric cognitive disorders. 2009, Vol 27, Num 4, pp 318-321, issn 1420-8008, 4 p.Article

Long-term efficacy and safety of celecoxib in Alzheimer's diseaseSOININEN, Hilkka; WEST, Christine; ROBBINS, Jeffery et al.Dementia and geriatric cognitive disorders. 2007, Vol 23, Num 1, pp 8-21, issn 1420-8008, 14 p.Article

β-Amyloid (1-42) affects MTT reduction in astrocytes : implications for vesicular trafficking and cell functionalityKEROKOSKI, Petri; SOININEN, Hilkka; PIRTTILÄ, Tuula et al.Neurochemistry international. 2001, Vol 38, Num 2, pp 127-134, issn 0197-0186Article

Immuno-PCR-based quantification of multiple phosphorylated tau-epitopes linked to Alzheimer's diseaseSINGER, David; SOININEN, Hilkka; ALAFUZOFF, Irina et al.Analytical & bioanalytical chemistry (Print). 2009, Vol 395, Num 7, pp 2263-2267, issn 1618-2642, 5 p.Article

Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer diseasePARKKINEN, Laura; SOININEN, Hilkka; ALAFUZOFF, Irina et al.Journal of neuropathology and experimental neurology. 2003, Vol 62, Num 4, pp 363-367, issn 0022-3069, 5 p.Article

Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neuronsKEROKOSKI, Petri; SUURONEN, Tiina; SALMINEN, Antero et al.Neuroscience letters. 2004, Vol 368, Num 2, pp 181-185, issn 0304-3940, 5 p.Article

DNA fragmentation, gliosis and histological hallmarks of Alzheimer's diseaseOVERMYER, Margit; KRASZPULSKI, Michal; HELISALMI, Seppo et al.Acta neuropathologica. 2000, Vol 100, Num 6, pp 681-687, issn 0001-6322Article

AMP―activated protein kinase: a potential player in Alzheimer's diseaseSALMINEN, Antero; KAARNIRANTA, Kai; HAAPASALO, Annakaisa et al.Journal of neurochemistry. 2011, Vol 118, Num 3-4, pp 460-474, issn 0022-3042, 15 p.Article

Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35KEROKOSKI, Petri; SUURONEN, Tiina; SALMINEN, Antero et al.Molecular brain research. 2002, Vol 106, Num 1-2, pp 50-56, issn 0169-328X, 7 p.Article

CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairmentHERUKKA, Sanna-Kaisa; HALLIKAINEN, Merja; SOININEN, Hilkka et al.Neurology. 2005, Vol 64, Num 7, pp 1294-1297, issn 0028-3878, 4 p.Article

An Association Study Between Granulin Gene Polymorphisms and Alzheimer's Disease in Finnish PopulationVISWANATHAN, Jayashree; MÄKINEN, Petra; HELISALMI, Seppo et al.American journal of medical genetics. Part B, Neuropsychiatric genetics. 2009, Vol 150, Num 5, pp 747-750, issn 1552-4841, 4 p.Article

Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patientsCLARKE, Nicholas A; SOININEN, Hilkka; GUSTAFSON, Lars et al.International journal of geriatric psychiatry. 2001, Vol 16, Num 11, pp 1104-1106, issn 0885-6230Article

Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNA^glnFINNILÄ, Saara; AUTERE, Jaana; LEHTOVIRTA, Maarit et al.Journal of medical genetics. 2001, Vol 38, Num 6, pp 400-405, issn 0022-2593Article

Incidence of stroke in people with Alzheimer disease: A national register―based approachTOLPPANEN, Anna-Maija; LAVIKAINEN, Piia; SOLOMON, Alina et al.Neurology. 2013, Vol 80, Num 4, pp 353-358, issn 0028-3878, 6 p.Article

Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's diseaseHELISALMI, Seppo; TARVAINEN, Timo; VEPSÄLÄINEN, Saila et al.Neuroscience letters. 2008, Vol 441, Num 2, pp 233-236, issn 0304-3940, 4 p.Article

Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brainXU LI; AN, Wen-Lin; ALAFUZOFF, Irina et al.Neuroreport (Oxford). 2004, Vol 15, Num 14, pp 2237-2240, issn 0959-4965, 4 p.Article

Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatmentFERRIS, Steven; NORDBERG, Agneta; SOININEN, Hilkka et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 8, pp 635-646, issn 1744-6872, 12 p.Article

Somatostatin genetic variants modify the risk for Alzheimer's disease among Finnish patientsVEPSALAINEN, Saila; HELISALMI, Seppo; KOIVISTO, Anne M et al.Journal of neurology. 2007, Vol 254, Num 11, pp 1504-1508, issn 0340-5354, 5 p.Article

Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: Potential for pharmacological interventionKIVIPELTO, Miia; LAAKSO, Mikko P; TUOMILEHTO, Jaakko et al.CNS drugs. 2002, Vol 16, Num 7, pp 435-444, issn 1172-7047Article

Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohortTOLPPANEN, Anna-Maija; KETTUNEN, Raimo; AHONEN, Riitta et al.International journal of cardiology. 2013, Vol 170, Num 2, pp 195-201, issn 0167-5273, 7 p.Article

Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in womenPIRSKANEN, Mia; HILTUNEN, Mikko; MANNERMAA, Arto et al.European journal of human genetics. 2005, Vol 13, Num 9, pp 1000-1006, issn 1018-4813, 7 p.Article

Heparan sulfate proteoglycan 2 polymorphism in Alzheimer's disease and correlation with neuropathologyIIVONEN, Susan; HELISALMI, Seppo; MANNERWAA, Arto et al.Neuroscience letters. 2003, Vol 352, Num 2, pp 146-150, issn 0304-3940, 5 p.Article

Incidence and risk factors for Mild cognitive impairment: A population-based three-year follow-up study of cognitively healthy elderly subjectsTERVO, Susanna; KIVIPELTO, Miia; HÄNNINEN, Tuomo et al.Dementia and geriatric cognitive disorders. 2004, Vol 17, Num 3, pp 196-203, issn 1420-8008, 8 p.Article

Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's diseaseRIEDEL, Anett; MIETTINEN, Riitta; STIELER, Jens et al.Acta neuropathologica. 2003, Vol 106, Num 4, pp 291-302, issn 0001-6322, 12 p.Article

Relationship between apoE genotype and CSF β-amyloid (1-42) and tau in patients with probable and definite Alzheimer's diseaseTAPIOLA, Tero; PIRTTILÄ, Tuula; MEHTA, Pankaj D et al.Neurobiology of aging. 2000, Vol 21, Num 5, pp 735-740, issn 0197-4580Article